1. Home
  2. HCM vs NMRK Comparison

HCM vs NMRK Comparison

Compare HCM & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • NMRK
  • Stock Information
  • Founded
  • HCM 2000
  • NMRK 1929
  • Country
  • HCM Hong Kong
  • NMRK United States
  • Employees
  • HCM N/A
  • NMRK N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • NMRK Real Estate
  • Sector
  • HCM Health Care
  • NMRK Finance
  • Exchange
  • HCM Nasdaq
  • NMRK Nasdaq
  • Market Cap
  • HCM 2.6B
  • NMRK 2.3B
  • IPO Year
  • HCM N/A
  • NMRK 2017
  • Fundamental
  • Price
  • HCM $14.98
  • NMRK $12.10
  • Analyst Decision
  • HCM Hold
  • NMRK Buy
  • Analyst Count
  • HCM 1
  • NMRK 4
  • Target Price
  • HCM $19.00
  • NMRK $16.83
  • AVG Volume (30 Days)
  • HCM 85.0K
  • NMRK 1.1M
  • Earning Date
  • HCM 03-19-2025
  • NMRK 05-02-2025
  • Dividend Yield
  • HCM N/A
  • NMRK 0.99%
  • EPS Growth
  • HCM N/A
  • NMRK 41.67
  • EPS
  • HCM 0.04
  • NMRK 0.34
  • Revenue
  • HCM $630,201,000.00
  • NMRK $2,738,502,000.00
  • Revenue This Year
  • HCM $28.98
  • NMRK $13.31
  • Revenue Next Year
  • HCM $20.41
  • NMRK $8.93
  • P/E Ratio
  • HCM $69.52
  • NMRK $35.62
  • Revenue Growth
  • HCM N/A
  • NMRK 10.85
  • 52 Week Low
  • HCM $12.84
  • NMRK $9.44
  • 52 Week High
  • HCM $21.92
  • NMRK $16.10
  • Technical
  • Relative Strength Index (RSI)
  • HCM 47.89
  • NMRK 37.59
  • Support Level
  • HCM $14.00
  • NMRK $12.26
  • Resistance Level
  • HCM $15.57
  • NMRK $12.97
  • Average True Range (ATR)
  • HCM 0.47
  • NMRK 0.40
  • MACD
  • HCM -0.11
  • NMRK -0.02
  • Stochastic Oscillator
  • HCM 37.12
  • NMRK 29.63

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About NMRK Newmark Group Inc.

Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.

Share on Social Networks: